
Yoderm (later rebranded as Apostrophe) was a teledermatology platform connecting patients with board-certified dermatologists for personalized skincare treatments including acne, rosacea, and hyperpigmentation. Founded in 2012 and rebranded to Apostrophe in 2017, it was acquired by Hims & Hers Health in 2021 for $190 million and shut down in March 2025.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account